NLRC4 and early-onset autosomal dominant Alzheimer disease: Although astrocytic NLRC4 has been implicated in Alzheimer’s disease and multiple sclerosis38,39, the present report using the TCGA glioma dataset is the first description of NLRC4 expression and its effects on the clinical prognosis in patients with astrocytomas (Fig. 4).